ARS Pharmaceuticals (SPRY) Working capital

annual working capital:

$310.86M+$81.52M(+35.55%)
December 31, 2024

Summary

  • As of today (July 4, 2025), SPRY annual working capital is $310.86 million, with the most recent change of +$81.52 million (+35.55%) on December 31, 2024.
  • During the last 3 years, SPRY annual working capital has risen by +$258.31 million (+491.62%).
  • SPRY annual working capital is now at all-time high.

Performance

SPRY Working capital Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSPRYbalance sheet metrics

quarterly working capital:

$276.24M-$34.62M(-11.14%)
March 31, 2025

Summary

  • As of today (July 4, 2025), SPRY quarterly working capital is $276.24 million, with the most recent change of -$34.62 million (-11.14%) on March 31, 2025.
  • Over the past year, SPRY quarterly working capital has increased by +$53.71 million (+24.14%).
  • SPRY quarterly working capital is now -11.14% below its all-time high of $310.86 million, reached on December 31, 2024.

Performance

SPRY quarterly working capital Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSPRYbalance sheet metrics

Working capital Formula

Working Capital = Current Assets − Current Liabilities

SPRY Working capital Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+35.5%+24.1%
3 y3 years+491.6%-
5 y5 years+1610.6%+425.7%

SPRY Working capital Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+491.6%-11.1%+628.3%
5 y5-yearat high+1610.6%-11.1%+628.3%
alltimeall timeat high+1610.6%-11.1%+628.3%

SPRY Working capital History

DateAnnualQuarterly
Mar 2025
-
$276.24M(-11.1%)
Dec 2024
$310.86M(+35.5%)
$310.86M(+61.8%)
Sep 2024
-
$192.17M(-10.2%)
Jun 2024
-
$214.01M(-3.8%)
Mar 2024
-
$222.53M(-3.0%)
Dec 2023
$229.34M
$229.34M(-1.7%)
Sep 2023
-
$233.29M(-4.8%)
DateAnnualQuarterly
Jun 2023
-
$244.98M(-4.9%)
Mar 2023
-
$257.51M(-5.4%)
Dec 2022
$272.26M(+418.2%)
$272.26M(+617.8%)
Jun 2022
-
$37.93M(-27.8%)
Dec 2021
$52.54M(+189.1%)
-
Dec 2021
-
$52.54M
Dec 2020
$18.17M
-

FAQ

  • What is ARS Pharmaceuticals annual working capital?
  • What is the all time high annual working capital for ARS Pharmaceuticals?
  • What is ARS Pharmaceuticals annual working capital year-on-year change?
  • What is ARS Pharmaceuticals quarterly working capital?
  • What is the all time high quarterly working capital for ARS Pharmaceuticals?
  • What is ARS Pharmaceuticals quarterly working capital year-on-year change?

What is ARS Pharmaceuticals annual working capital?

The current annual working capital of SPRY is $310.86M

What is the all time high annual working capital for ARS Pharmaceuticals?

ARS Pharmaceuticals all-time high annual working capital is $310.86M

What is ARS Pharmaceuticals annual working capital year-on-year change?

Over the past year, SPRY annual working capital has changed by +$81.52M (+35.55%)

What is ARS Pharmaceuticals quarterly working capital?

The current quarterly working capital of SPRY is $276.24M

What is the all time high quarterly working capital for ARS Pharmaceuticals?

ARS Pharmaceuticals all-time high quarterly working capital is $310.86M

What is ARS Pharmaceuticals quarterly working capital year-on-year change?

Over the past year, SPRY quarterly working capital has changed by +$53.71M (+24.14%)
On this page